Amphion Innovations plc,
Subscription of 2,272,728 New Ordinary Shares

London and New York, 12 November 2007 - London and New York, 12 November 2007- Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces that it has raised £500,000 (before expenses) by the issue of 2,272,728 new ordinary shares of 1p each in the capital of the Company (the "New Ordinary Shares") to an institutional investor by way of subscription at an issue price of 22 pence per New Ordinary Share to enable the Company to invest in current and new Partner Companies and to provide working capital for the Company. The New Ordinary Shares will represent approximately 1.8 per cent of the existing Amphion share capital.

Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM. The New Ordinary Shares will, when issued, rank equally in all respects with the existing Ordinary Shares, including the right to receive any dividend or other distribution declared, made or paid following Admission. It is expected that Admission will become effective and that dealings in the New Ordinary Shares will commence 15 November 2007.

Following admission of the New Ordinary Shares, the Company will have 128,292,029 ordinary shares in issue with each ordinary share holding one voting right.

For further information please contact

Amphion Innovations plc
Charlie Morgan, Director of Communications
+1 212 210 6224

Financial Dynamics
Ben Atwell
+44 20 7831 3113

Charles Stanley Securities
Mark Taylor / Freddy Crossley
+44 20 7149 6000

About Amphion Innovations plc
Amphion Innovations plc (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors. Amphion uses a focused, hands-on company building approach based on decades of experience in both the US and UK.

On the web: